Paper40568420
High Efficacy of Rose Bengal in Reducing the Pathogenicity of Escherichia coli Isolated From Diarrheal Infections.
Malanda CDB and 7 others. Int J Microbiol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. High Efficacy of Rose Bengal in Reducing the Pathogenicity of Escherichia coli Isolated From Diarrheal Infections. Papers, record 40568420. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40568420
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High Efficacy of Rose Bengal in Reducing the Pathogenicity of Escherichia coli Isolated From Diarrheal Infections.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37628911 | Molecular and Genomic Analysis of the Virulence Factors and Potential Transmission of Hybrid Enteropathogenic and Enterotoxigenic Escherichia coli (EPEC/ETEC) Strains Isolated in South Korea. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37628911 | PubMed |
| 2 | 24092857 | Recent advances in understanding enteric pathogenic Escherichia coli. | Clin Microbiol Rev | 2013 | https://conductscience.org/library/papers/24092857 | PubMed |
| 3 | 15668384 | A genomic population genetics analysis of the pathogenic enterocyte effacement island in Escherichia coli: the search for the unit of selection. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15668384 | PubMed |
| 4 | 8795195 | Mechanisms of acid resistance in enterohemorrhagic Escherichia coli. | Appl Environ Microbiol | 1996 | https://conductscience.org/library/papers/8795195 | PubMed |
| 5 | 38725978 | Involvement of the Bacillus SecYEG Pathway in Biosurfactant Production and Biofilm Formation. | Int J Microbiol | 2024 | https://conductscience.org/library/papers/38725978 | PubMed |
| 6 | 32069253 | Antibiotic resistance and biofilm formation in children with Enteropathogenic Escherichia coli (EPEC) in Brazilian Amazon. | J Infect Dev Ctries | 2019 | https://conductscience.org/library/papers/32069253 | PubMed |
| 7 | 40084209 | Uropathogen profiles and their antimicrobial resistance patterns in patients: a three-year retrospective study in Sichuan region. | Front Public Health | 2025 | https://conductscience.org/library/papers/40084209 | PubMed |
| 8 | 38150488 | Human corneal epithelial cell and fibroblast migration and growth factor secretion after rose bengal photodynamic therapy (RB-PDT) and the effect of conditioned medium. | PLoS One | 2023 | https://conductscience.org/library/papers/38150488 | PubMed |
| 9 | 27394008 | Rose bengal uptake by E. faecalis and F. nucleatum and light-mediated antibacterial activity measured by flow cytometry. | J Photochem Photobiol B | 2016 | https://conductscience.org/library/papers/27394008 | PubMed |
| 10 | 35004350 | Galleria mellonella as a Suitable Model of Bacterial Infection: Past, Present and Future. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/35004350 | PubMed |
| 11 | 34576083 | Virulence Factors of Enteric Pathogenic Escherichia coli: A Review. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34576083 | PubMed |
| 12 | 39994590 | Analysis of phylogroups, biofilm formation, virulence factors, antibiotic resistance and molecular typing of uropathogenic Escherichia coli strains isolated from patients with recurrent and non-recurrent urinary tract infections. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/39994590 | PubMed |
| 13 | 36077560 | Development of a Polymeric Film Entrapping Rose Bengal and Iodide Anion for the Light-Induced Generation and Release of Bactericidal Hydrogen Peroxide. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077560 | PubMed |
| 14 | 35181503 | TorR/TorS Two-Component system resists extreme acid environment by regulating the key response factor RpoS in Escherichia coli. | Gene | 2022 | https://conductscience.org/library/papers/35181503 | PubMed |
| 15 | 32826992 | The population genetics of pathogenic Escherichia coli. | Nat Rev Microbiol | 2021 | https://conductscience.org/library/papers/32826992 | PubMed |
| 16 | 38001938 | Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities. | Biomedicines | 2023 | https://conductscience.org/library/papers/38001938 | PubMed |
| 17 | 28151483 | Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death. | Cell Death Dis | 2017 | https://conductscience.org/library/papers/28151483 | PubMed |
| 18 | 33815340 | Re-evaluation of a Neonatal Mouse Model of Infection With Enterotoxigenic Escherichia coli. | Front Microbiol | 2021 | https://conductscience.org/library/papers/33815340 | PubMed |
| 19 | 15494746 | Escherichia coli acid resistance: tales of an amateur acidophile. | Nat Rev Microbiol | 2004 | https://conductscience.org/library/papers/15494746 | PubMed |
| 20 | 20694026 | A field guide to bacterial swarming motility. | Nat Rev Microbiol | 2010 | https://conductscience.org/library/papers/20694026 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40568420
GET https://conductscience.org/api/papers/v1/40568420/references?page=2